285 related articles for article (PubMed ID: 9171222)
1. Interleukin 6 and AIDS-associated Kaposi's sarcoma: a nested case control study within the Multicenter AIDS Cohort Study.
Dourado I; Martínez-Maza O; Kishimoto T; Suzuki H; Detels R
AIDS Res Hum Retroviruses; 1997 Jun; 13(9):781-8. PubMed ID: 9171222
[TBL] [Abstract][Full Text] [Related]
2. Comparison of constitutive cytokine release in high and low histologic grade AIDS-related Kaposi's sarcoma cell strains and in sera from HIV+/KS+ and HIV+/KS- patients.
Bailer RT; Lazo A; Ng-Bautista CL; Hout BL; Ness GM; Hegtvedt AK; Blakeslee JR; Stephens RE; Brierley GP; Mallery SR
J Interferon Cytokine Res; 1995 May; 15(5):473-83. PubMed ID: 7648450
[TBL] [Abstract][Full Text] [Related]
3. Incidence of Kaposi's sarcoma in a cohort of homosexual men infected with the human immunodeficiency virus type 1. The Multicenter AIDS Cohort Study Group.
Jacobson LP; Muñoz A; Fox R; Phair JP; Dudley J; Obrams GI; Kingsley LA; Polk BF
J Acquir Immune Defic Syndr (1988); 1990; 3 Suppl 1():S24-31. PubMed ID: 2395082
[TBL] [Abstract][Full Text] [Related]
4. Composite risk score for Kaposi's sarcoma based on a case-control and longitudinal study in the Multicenter AIDS Cohort Study (MACS) population.
Armenian HK; Hoover DR; Rubb S; Metz S; Kaslow R; Visscher B; Chmiel J; Kingsley L; Saah A
Am J Epidemiol; 1993 Aug; 138(4):256-65. PubMed ID: 8356966
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for Kaposi's sarcoma in HIV-positive subjects in Uganda.
Ziegler JL; Newton R; Katongole-Mbidde E; Mbulataiye S; De Cock K; Wabinga H; Mugerwa J; Katabira E; Jaffe H; Parkin DM; Reeves G; Weiss R; Beral V
AIDS; 1997 Nov; 11(13):1619-26. PubMed ID: 9365767
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology of AIDS-related Kaposi's sarcoma in Europe over 10 years. AIDS in Europe Study Group.
Hermans P; Lundgren J; Sommereijns B; Pedersen C; Vella S; Katlama C; Lüthy R; Pinching AJ; Gerstoft J; Pehrson P; Clumeck N
AIDS; 1996 Jul; 10(8):911-7. PubMed ID: 8828749
[TBL] [Abstract][Full Text] [Related]
7. Recent developments in sexually transmitted diseases: is Kaposi's sarcoma a sexually transmitted disease?
Felman YM
Cutis; 1990 Oct; 46(4):303-6. PubMed ID: 2261787
[TBL] [Abstract][Full Text] [Related]
8. Association of IL-6, IL-10 and CXCL10 serum concentrations with visceral Kaposi's sarcoma in people living with HIV/AIDS.
Lopes TRR; Gonçales JP; Silva Júnior JVJ; Lorena VMB; Toscano ALCC; Akamatsu SM; Salles AC; Tozetto-Mendoza TR; Morais VMS; Coêlho MRCD
Hum Immunol; 2020 Jan; 81(1):26-31. PubMed ID: 31866063
[TBL] [Abstract][Full Text] [Related]
9. Relationship of serum levels of oncostatin M to AIDS-related and classic Kaposi's sarcoma.
Hamilton AS; Radka SF; Bernstein L; Gill PS; Gonsalves M; Naemura JR; Ross RK
J Acquir Immune Defic Syndr (1988); 1994 Apr; 7(4):410-4. PubMed ID: 7907664
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and associated risk factors for Kaposi's sarcoma among HIV-positive patients in a referral hospital in Northern Tanzania: a retrospective hospital-based study.
Semango GP; Charles RM; Swai CI; Mremi A; Amsi P; Sonda T; Shao ER; Mavura DR; Joosten LAB; Sauli E; Nyindo M
BMC Cancer; 2018 Dec; 18(1):1258. PubMed ID: 30558571
[TBL] [Abstract][Full Text] [Related]
11. [Immune activation in AIDS related Kaposi's sarcoma].
Zhu B; Wu NP; Hoxtermann S; Bader A; Brockmeyer N
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2003 Apr; 32(2):101-3. PubMed ID: 12734931
[TBL] [Abstract][Full Text] [Related]
12. Kaposi's sarcoma as a sexually transmissible infection: an analysis of Australian AIDS surveillance data. The National HIV Surveillance Committee.
Elford J; McDonald A; Kaldor J
AIDS; 1993 Dec; 7(12):1667-71. PubMed ID: 8286078
[TBL] [Abstract][Full Text] [Related]
13. Kaposi's sarcoma in HIV infected women in Germany: more evidence for sexual transmission. A report of 10 cases and review of the literature.
Albrecht H; Helm EB; Plettenberg A; Emminger C; Heise W; Schwartländer B; Stellbrink HJ
Genitourin Med; 1994 Dec; 70(6):394-8. PubMed ID: 7705856
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for Kaposi's sarcoma in the Vancouver Lymphadenopathy-AIDS Study.
Archibald CP; Schechter MT; Craib KJ; Le TN; Douglas B; Willoughby B; O'Shaughnessy M
J Acquir Immune Defic Syndr (1988); 1990; 3 Suppl 1():S18-23. PubMed ID: 2395081
[TBL] [Abstract][Full Text] [Related]
15. Distinct serum cytokines in AIDS-related skin diseases.
Breuer-McHam JN; Marshall GD; Lewis DE; Duvic M
Viral Immunol; 1998; 11(4):215-20. PubMed ID: 10189188
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology of Kaposi's sarcoma.
Beral V
Cancer Surv; 1991; 10():5-22. PubMed ID: 1821323
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for Kaposi's sarcoma in patients with advanced human immunodeficiency virus disease treated with zidovudine. Zidovudine Epidemiology Study Group.
Gallant JE; Moore RD; Richman DD; Keruly J; Chaisson RE
Arch Intern Med; 1994 Mar; 154(5):566-72. PubMed ID: 8122950
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for Kaposi's sarcoma in human immunodeficiency virus patients after initiation of antiretroviral therapy: A nested case-control study in Kenya.
Lupia R; Wabuyia PB; Otiato P; Fang CT; Tsai FJ
J Microbiol Immunol Infect; 2017 Dec; 50(6):781-788. PubMed ID: 26712092
[TBL] [Abstract][Full Text] [Related]
19. Kaposi's sarcoma: a reevaluation.
Orfanos CE; Husak R; Wölfer U; Garbe C
Recent Results Cancer Res; 1995; 139():275-96. PubMed ID: 7541146
[TBL] [Abstract][Full Text] [Related]
20. Nadir B cell counts are significantly correlated with the risk of Kaposi's sarcoma.
Stebbing J; Gazzard B; Newsom-Davis T; Nelson M; Patterson S; Gotch F; Mandalia S; Bower M
Int J Cancer; 2004 Jan; 108(3):473-4. PubMed ID: 14648716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
